-       Report 
- August 2025
-  150 Pages 
- Global 
   From       €5295EUR$5,950USD£4,661GBP 
          -       Report 
- July 2025
-  110 Pages 
- Global 
   From       €5295EUR$5,950USD£4,661GBP 
            -       Report 
- October 2025
-  188 Pages 
- Global 
   From       €3155EUR$3,545USD£2,777GBP 
      €3505EUR$3,939USD£3,085GBP 
            -       Report 
- October 2025
-  187 Pages 
- Global 
   From       €3155EUR$3,545USD£2,777GBP 
      €3505EUR$3,939USD£3,085GBP 
            -       Report 
- August 2025
-  188 Pages 
- Global 
   From       €3155EUR$3,545USD£2,777GBP 
      €3505EUR$3,939USD£3,085GBP 
             -       Report 
- August 2025
-  182 Pages 
- Global 
   From       €3155EUR$3,545USD£2,777GBP 
      €3505EUR$3,939USD£3,085GBP 
            -       Report 
- August 2025
-  196 Pages 
- Global 
   From       €3155EUR$3,545USD£2,777GBP 
      €3505EUR$3,939USD£3,085GBP 
            -       Report 
- August 2025
-  184 Pages 
- Global 
   From       €3155EUR$3,545USD£2,777GBP 
      €3505EUR$3,939USD£3,085GBP 
            -       Report 
- August 2025
-  195 Pages 
- Global 
   From       €3155EUR$3,545USD£2,777GBP 
      €3505EUR$3,939USD£3,085GBP 
            -       Report 
- August 2025
-  194 Pages 
- Global 
   From       €3155EUR$3,545USD£2,777GBP 
      €3505EUR$3,939USD£3,085GBP 
            -       Report 
- August 2025
-  191 Pages 
- Global 
   From       €3155EUR$3,545USD£2,777GBP 
      €3505EUR$3,939USD£3,085GBP 
            -       Report 
- August 2025
-  195 Pages 
- Global 
   From       €3155EUR$3,545USD£2,777GBP 
      €3505EUR$3,939USD£3,085GBP 
            -       Report 
- August 2025
-  189 Pages 
- Global 
   From       €3155EUR$3,545USD£2,777GBP 
      €3505EUR$3,939USD£3,085GBP 
            -       Report 
- August 2025
-  186 Pages 
- Global 
   From       €3155EUR$3,545USD£2,777GBP 
      €3505EUR$3,939USD£3,085GBP 
            -       Report 
- August 2025
-  192 Pages 
- Global 
   From       €3155EUR$3,545USD£2,777GBP 
      €3505EUR$3,939USD£3,085GBP 
          -       Report 
- October 2025
-  452 Pages 
- Global 
   From       €5206EUR$5,850USD£4,582GBP 
          -       Report 
- October 2025
-  276 Pages 
- Global 
   From       €5206EUR$5,850USD£4,582GBP 
          -       Report 
- October 2025
-  93 Pages 
- Global 
   From       €5206EUR$5,850USD£4,582GBP 
          -       Report 
- October 2025
-  150 Pages 
- Global 
   From       €5206EUR$5,850USD£4,582GBP 
          -       Report 
- September 2025
-  250 Pages 
- Global 
   From       €3995EUR$4,490USD£3,517GBP 
       
      The Arthritis Drug market is a subset of the Immune Disorders Drugs market, which includes treatments for a variety of conditions related to the immune system. Arthritis drugs are used to treat the inflammation and pain associated with arthritis, a condition that affects the joints and surrounding tissues. These drugs can be divided into two main categories: non-steroidal anti-inflammatory drugs (NSAIDs) and disease-modifying antirheumatic drugs (DMARDs). NSAIDs are used to reduce inflammation and    pain, while DMARDs are used to slow the progression of the disease.
The Arthritis Drug market is highly competitive, with a number of large pharmaceutical companies offering a variety of treatments. Some of the major players in the market include Pfizer, Merck, AbbVie, Johnson & Johnson, and Novartis. Show Less   Read more